194 related articles for article (PubMed ID: 36291092)
1. A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger.
Bastida JM; Malvestiti S; Boeckelmann D; Palma-Barqueros V; Wolter M; Lozano ML; Glonnegger H; Benito R; Zaninetti C; Sobotta F; Schilling FH; Morgan NV; Freson K; Rivera J; Zieger B
Cells; 2022 Oct; 11(20):. PubMed ID: 36291092
[TBL] [Abstract][Full Text] [Related]
2. Novel
Jurk K; Adenaeuer A; Sollfrank S; Groß K; Häuser F; Czwalinna A; Erkel J; Fritsch N; Marandiuc D; Schaller M; Lackner KJ; Rossmann H; Bergmann F
Cells; 2022 Sep; 11(19):. PubMed ID: 36231035
[TBL] [Abstract][Full Text] [Related]
3. Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation.
Freson K; Matthijs G; Thys C; Mariën P; Hoylaerts MF; Vermylen J; Van Geet C
Hum Mol Genet; 2002 Jan; 11(2):147-52. PubMed ID: 11809723
[TBL] [Abstract][Full Text] [Related]
4. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation.
Freson K; Devriendt K; Matthijs G; Van Hoof A; De Vos R; Thys C; Minner K; Hoylaerts MF; Vermylen J; Van Geet C
Blood; 2001 Jul; 98(1):85-92. PubMed ID: 11418466
[TBL] [Abstract][Full Text] [Related]
5. GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis.
Saultier P; Cabantous S; Puceat M; Peiretti F; Bigot T; Saut N; Bordet JC; Canault M; van Agthoven J; Loosveld M; Payet-Bornet D; Potier D; Falaise C; Bernot D; Morange PE; Alessi MC; Poggi M
J Thromb Haemost; 2021 Sep; 19(9):2287-2301. PubMed ID: 34060193
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genetic heterogeneity arising from a novel substitution at amino acid position Val205 in GATA1 related X-linked thrombocytopenia with dyserythropoietic anemia.
Jamwal M; Aggarwal A; Sharma P; Bansal D; Maitra A; Das R
Blood Cells Mol Dis; 2020 Mar; 81():102391. PubMed ID: 31865264
[No Abstract] [Full Text] [Related]
7. X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation.
Tubman VN; Levine JE; Campagna DR; Monahan-Earley R; Dvorak AM; Neufeld EJ; Fleming MD
Blood; 2007 Apr; 109(8):3297-9. PubMed ID: 17209061
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytopenia and CD34 expression is decoupled from α-granule deficiency with mutation of the first growth factor-independent 1B zinc finger.
Rabbolini DJ; Morel-Kopp MC; Chen Q; Gabrielli S; Dunlop LC; Chew LP; Blair N; Brighton TA; Singh N; Ng AP; Ward CM; Stevenson WS
J Thromb Haemost; 2017 Nov; 15(11):2245-2258. PubMed ID: 28880435
[TBL] [Abstract][Full Text] [Related]
9. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1.
Nichols KE; Crispino JD; Poncz M; White JG; Orkin SH; Maris JM; Weiss MJ
Nat Genet; 2000 Mar; 24(3):266-70. PubMed ID: 10700180
[TBL] [Abstract][Full Text] [Related]
10. A novel GATA1 variant p.G229D causing the defect of procoagulant platelet formation.
Ding B; Mao Y; Li Y; Xin M; Jiang S; Hu X; Xu Q; Ding Q; Wang X
Thromb Res; 2024 Feb; 234():39-50. PubMed ID: 38159323
[TBL] [Abstract][Full Text] [Related]
11. A Child With Dyserythropoietic Anemia and Megakaryocyte Dysplasia Due to a Novel 5'UTR GATA1s Splice Mutation.
Zucker J; Temm C; Czader M; Nalepa G
Pediatr Blood Cancer; 2016 May; 63(5):917-21. PubMed ID: 26713410
[TBL] [Abstract][Full Text] [Related]
12. New germline GATA1 variant in females with anemia and thrombocytopenia.
Svidnicki MCCM; Filho MAF; Brandão MM; Dos Santos M; de Oliveira Dias R; Tavares RS; Assis-Mendonça GR; Traina F; Saad STO
Blood Cells Mol Dis; 2021 May; 88():102545. PubMed ID: 33611093
[TBL] [Abstract][Full Text] [Related]
13. Surgery of a cyanotic heart defect in an 11-year-old boy with thrombocytopenic thrombocytopathy and severe anemia due to a GATA-1 defect: hemostatic therapy.
Hoefer J; Streif W; Kilo J; Grimm M; Berger G; Velik-Salchner C
Klin Padiatr; 2012 Oct; 224(6):382-5. PubMed ID: 22915449
[TBL] [Abstract][Full Text] [Related]
14. GATA1 mutations in red cell disorders.
Ling T; Crispino JD
IUBMB Life; 2020 Jan; 72(1):106-118. PubMed ID: 31652397
[TBL] [Abstract][Full Text] [Related]
15. Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis.
Balduini CL; Pecci A; Loffredo G; Izzo P; Noris P; Grosso M; Bergamaschi G; Rosti V; Magrini U; Ceresa IF; Conti V; Poggi V; Savoia A
Thromb Haemost; 2004 Jan; 91(1):129-40. PubMed ID: 14691578
[TBL] [Abstract][Full Text] [Related]
16. GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1.
Kuhl C; Atzberger A; Iborra F; Nieswandt B; Porcher C; Vyas P
Mol Cell Biol; 2005 Oct; 25(19):8592-606. PubMed ID: 16166640
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutions.
Freson K; Thys C; Wittewrongel C; Vermylen J; Hoylaerts MF; Van Geet C
Hum Genet; 2003 Jan; 112(1):42-9. PubMed ID: 12483298
[TBL] [Abstract][Full Text] [Related]
18. Selective impairment of platelet activation to collagen in the absence of GATA1.
Hughan SC; Senis Y; Best D; Thomas A; Frampton J; Vyas P; Watson SP
Blood; 2005 Jun; 105(11):4369-76. PubMed ID: 15701726
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor GATA1 regulates NBEAL2 expression through a long-distance enhancer.
Wijgaerts A; Wittevrongel C; Thys C; Devos T; Peerlinck K; Tijssen MR; Van Geet C; Freson K
Haematologica; 2017 Apr; 102(4):695-706. PubMed ID: 28082341
[TBL] [Abstract][Full Text] [Related]
20. Regulation of GATA1 levels in erythropoiesis.
Gutiérrez L; Caballero N; Fernández-Calleja L; Karkoulia E; Strouboulis J
IUBMB Life; 2020 Jan; 72(1):89-105. PubMed ID: 31769197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
